GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bio-Thera Solutions Ltd (SHSE:688177) » Definitions » EV-to-EBITDA

Bio-Thera Solutions (SHSE:688177) EV-to-EBITDA : -25.51 (As of Jun. 25, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Bio-Thera Solutions EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Bio-Thera Solutions's enterprise value is ¥9,103.3 Mil. Bio-Thera Solutions's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-356.8 Mil. Therefore, Bio-Thera Solutions's EV-to-EBITDA for today is -25.51.

The historical rank and industry rank for Bio-Thera Solutions's EV-to-EBITDA or its related term are showing as below:

SHSE:688177' s EV-to-EBITDA Range Over the Past 10 Years
Min: -150.42   Med: -24.98   Max: 99.69
Current: -25.51

During the past 8 years, the highest EV-to-EBITDA of Bio-Thera Solutions was 99.69. The lowest was -150.42. And the median was -24.98.

SHSE:688177's EV-to-EBITDA is ranked worse than
100% of 459 companies
in the Biotechnology industry
Industry Median: 8.66 vs SHSE:688177: -25.51

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-25), Bio-Thera Solutions's stock price is ¥21.17. Bio-Thera Solutions's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-0.900. Therefore, Bio-Thera Solutions's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Bio-Thera Solutions EV-to-EBITDA Historical Data

The historical data trend for Bio-Thera Solutions's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Thera Solutions EV-to-EBITDA Chart

Bio-Thera Solutions Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial - -26.49 56.31 -20.76 -57.11

Bio-Thera Solutions Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -19.04 -18.89 -21.25 -57.11 -41.91

Competitive Comparison of Bio-Thera Solutions's EV-to-EBITDA

For the Biotechnology subindustry, Bio-Thera Solutions's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bio-Thera Solutions's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bio-Thera Solutions's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Bio-Thera Solutions's EV-to-EBITDA falls into.



Bio-Thera Solutions EV-to-EBITDA Calculation

Bio-Thera Solutions's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=9103.346/-356.826
=-25.51

Bio-Thera Solutions's current Enterprise Value is ¥9,103.3 Mil.
Bio-Thera Solutions's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-356.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bio-Thera Solutions  (SHSE:688177) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Bio-Thera Solutions's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=21.17/-0.900
=At Loss

Bio-Thera Solutions's share price for today is ¥21.17.
Bio-Thera Solutions's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0.900.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Bio-Thera Solutions EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Bio-Thera Solutions's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Bio-Thera Solutions (SHSE:688177) Business Description

Traded in Other Exchanges
N/A
Address
5th Floor, Building A6, 11 Kaiyuan Avenue, Guangzhou High-tech Industrial Development Zone, Science City, Guangdong Province, Guangzhou, CHN, 510530
Bio-Thera Solutions Ltd is engaged in research, development, and production of drugs and biosimilars. The company provides drug research and development; biotechnology consulting and communication services; services; medical research and experimental development; biological drug manufacturing; and pharmaceuticals retail.

Bio-Thera Solutions (SHSE:688177) Headlines

No Headlines